Mast Cell Activation Syndrome (MCAS): Diagnosis and What the Research Says About Supportive Supplements
Mast Cell Activation Syndrome (MCAS) is a condition in which mast cells—an important part of the immune system—become overly reactive. Because mast cells exist throughout the body, symptoms can affect multiple systems at once, making MCAS complex and sometimes difficult to diagnose.
Let’s walk through what mast cells do, how MCAS is diagnosed, and what the science says about supportive supplements.
What Are Mast Cells?
Mast cells are immune cells found in the:
- Skin
- Gut
- Lungs
- Blood vessels
- Nervous system
Their role is protective. When they detect a threat, they release chemical messengers such as histamine, prostaglandins, leukotrienes, and cytokines. These compounds help coordinate inflammation and healing (Molderings et al., 2011; Castells & Butterfield, 2019).
In MCAS, mast cells release these mediators too easily, too often, or in excessive amounts—sometimes without a clear trigger.
Common Symptoms of MCAS
Because mast cells are widely distributed, symptoms often involve more than one organ system at the same time.
Common symptoms include:
- Flushing, itching, or hives
- Nasal congestion or wheezing
- Abdominal pain, bloating, or diarrhea
- Headaches or brain fog
- Rapid heart rate or lightheadedness
- Fatigue
- Sensitivity to foods, smells, medications, heat, or stress
Symptoms often flare and subside and can resemble allergic reactions or even anaphylaxis.
How Is MCAS Diagnosed?
Diagnosis is not based on symptoms alone. International guidelines require all three of the following criteria (Weiler et al., 2019; Valent et al., 2024; Parente et al., 2023):
1. Recurrent Episodes Affecting Two or More Organ Systems
Symptoms must involve more than one body system at the same time—for example, skin symptoms plus digestive or cardiovascular symptoms.
2. Objective Laboratory Evidence of Mast Cell Activation
The most important test is serum tryptase, drawn within about four hours of a flare and compared to baseline.
Doctors use the “120% + 2 rule”:
Event tryptase ≥ baseline × 1.2 + 2 ng/mL.
If tryptase does not rise, supportive testing may include urine measurements of N-methylhistamine, leukotriene E4, or prostaglandin D2 metabolites.
3. Improvement With Mast-Cell–Directed Therapy
Symptom improvement with medications such as H1 antihistamines, H2 antihistamines, cromolyn, or leukotriene blockers supports the diagnosis.
If baseline tryptase is persistently elevated or other concerning features are present, additional testing for clonal mast cell disease (mastocytosis) may be recommended.
Standard Medical Treatment Comes First
First-line treatment typically includes:
- H1 and H2 antihistamines
- Mast cell stabilizers (such as cromolyn or ketotifen)
These therapies are considered foundational (Molderings et al., 2011; Castells & Butterfield, 2019).
Supplements, if used, are considered adjuncts—not replacements—for medical treatment.
A Reality Check About Supplements
Before exploring supportive nutrients, it’s important to understand:
- Most research is not specific to MCAS
- Many studies are cell-based or animal studies
- Large, dedicated MCAS trials are limited
- People with MCAS may react to fillers or additives
- Higher doses are not always better
Any supplementation plan should be individualized and ideally supervised by a clinician familiar with mast cell disorders.
Palmitoylethanolamide (PEA): A Promising Mast Cell Modulator
PEA is a naturally occurring fatty acid compound involved in regulating inflammation.
It works by:
- Activating PPAR-alpha receptors
- Modulating the endocannabinoid system
- Reducing mast cell activation
Early research identified what is sometimes called the “ALIAmide effect,” meaning PEA may calm overactive mast cells (Facci et al., 1995; Skaper et al., 2013).
Human studies relevant to mast cell activity show potential benefits in conditions such as functional dyspepsia, irritable bowel syndrome, allergic rhinitis, and mastocytosis.
Typical studied doses range from 300–600 mg daily, with some trials using up to 1200 mg short term. Higher doses do not always provide additional benefit (Gabrielsson et al., 2016).
Other Nutrients That Influence Mast Cells
Flavonoids
Certain plant compounds inhibit mast cell mediator release in laboratory and animal studies. These include:
- Quercetin
- Luteolin
- Resveratrol
- Curcumin
- EGCG (green tea extract)
Human studies most commonly use:
- Quercetin: 500–1000 mg daily
- Luteolin: 50–100 mg daily
- EGCG: 200–300 mg daily (higher doses may stress the liver)
MCAS-specific human trials remain limited.
Vitamins and Minerals
- Vitamin D: Deficiency is associated with increased mast cell activation.
- Vitamin C: Supports histamine degradation.
- Vitamin B6: May work synergistically with vitamin C.
- Magnesium and zinc: Show mast cell–stabilizing effects in experimental models.
Gut-Derived Metabolites
The gut microbiome plays a role in mast cell regulation. Short-chain fatty acids such as butyrate and propionate—produced by healthy gut bacteria—strongly inhibit mast cell activation in human models (Folkerts et al., 2020).
This highlights the importance of gut health in mast cell regulation. Check out my Gut Health Playlist to discover more on how to restore and protect your digestive system and gut microbiome.
The Bottom Line
MCAS diagnosis requires:
- Recurrent multi-system symptoms
- Laboratory confirmation of mast cell mediator elevation during flares
- Improvement with mast-cell–targeted therapy
Standard medications remain foundational.
Research suggests certain supplements—particularly PEA—may help calm mast cell activation at a biological level. Other supportive nutrients include flavonoids, vitamin D, vitamin C with B6, magnesium, zinc, and gut-derived short-chain fatty acids.
However:
- Dedicated MCAS trials are limited
- Individual tolerance varies
- Supplements are adjunctive, not replacements
- Professional supervision is essential
Mast cell biology is complex, and personalized care matters. With appropriate testing and guidance, it is possible to better understand your symptoms and create a strategy that supports immune balance. If you would like support from a local Functional Medicine practitioner to help assess and manage MCAS, you can search the Institute for Functional Medicine practitioner database here:
Find a practitioner: https://www.ifm.org/find-a-practitioner/
This directory allows you to search by location and credentials to find a provider who aligns with your needs.
Fullscript Supplement Resources
If mast cell activation may be contributing to your symptoms, certain research-supported supplements can provide adjunctive support alongside medical care.
You can find practitioner-selected options in my easy-to-access Dr. Patricia Approved Fullscript plan.
References
Molderings G et al. Mast cell activation disease: diagnostic workup and therapy. J Hematol Oncol. 2011. PMID: 21306600.
Castells M, Butterfield J. Mast cell activation syndrome and mastocytosis. J Allergy Clin Immunol Pract. 2019. PMID: 30910418.
Weiler C et al. AAAAI Mast Cell Disorders Committee Work Group Report: Mast Cell Activation Syndrome (MCAS) Diagnosis and Management. J Allergy Clin Immunol. 2019. PMID: 31537491.
Valent P et al. Reversible Elevation of Tryptase Over the Individual’s Baseline. Curr Allergy Asthma Rep. 2024. PMID: 38521914.
Parente R et al. Secretory and Membrane-Associated Biomarkers of Mast Cell Activation. Int J Mol Sci. 2023. PMID: 37109806.
Beck S et al. Biomarkers in Human Anaphylaxis. Front Immunol. 2019. PMID: 31057633.
Voelker D, Pongdee T. Urine Mast Cell Mediators in MCAS. Curr Allergy Asthma Rep. 2024. PMID: 38331348.
Hamilton M. Mast Cell Activation Syndrome and Gut Dysfunction. Curr Gastroenterol Rep. 2024. PMID: 38520738.
Romantowski J et al. Application of Allergy Diagnostic Methods in Mast Cell Disorders. Int J Mol Sci. 2021. PMID: 33668645.
Navarro-Navarro P et al. Improved diagnostic screening of clonal mast cell diseases. Blood. 2025.
Molderings G et al. Pharmacological treatment options for MCAD. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27180236.
Schofield J, Afrin L. Medication excipient reactivity in MCAS. Am J Med Sci. 2019. PMID: 31097234.
Facci L et al. Mast cells express a peripheral cannabinoid receptor. Proc Natl Acad Sci USA. 1995. PMID: 7724575.
Skaper SD et al. Glia and mast cells as targets for palmitoylethanolamide. Mol Neurobiol. 2013. PMID: 23440402.
Sarnelli G et al. Impaired duodenal PEA release underlies mast cell activation. Cell Mol Gastroenterol Hepatol. 2020. PMID: 33189806.
Ferrara AL et al. Altered endocannabinoid metabolism in mastocytosis. J Immunol Res. 2019. PMID: 31281611.
Cremon C et al. PEA and polydatin in IBS. Aliment Pharmacol Ther. 2017. PMID: 28083828.
Briskey D et al. PEA supplementation in allergic rhinitis. Nutrients. 2023. PMID: 38066668.
Gabrielsson L et al. PEA pharmacokinetics and efficacy. Br J Clin Pharmacol. 2016. PMID: 26817640.
Bortoletto R et al. PEA supplementation systematic review. Brain Behav Immun Health. 2024. PMID: 38719586.
Galla R et al. Dose-dependent effects of PEA. Int J Mol Sci. 2024. PMID: 39201487.
Theoharides TC, Bielory L. Mast cells as targets of dietary supplements. Ann Allergy Asthma Immunol. 2004. PMID: 15328675.
Kaag S, Lorentz A. Dietary effects on mast cells. Cells. 2023. PMID: 37960888.
Islam M et al. EGCG stabilizes mast cells in vivo. Inflammopharmacology. 2025. PMID: 39962387.
Liu Z et al. Vitamin D and mast cell stabilization. Allergy. 2017. PMID: 28261828.
Kazama I et al. Pyridoxine and vitamin C synergism. Cell Physiol Biochem. 2022. PMID: 35383741.
Kazama I et al. Magnesium and zinc stabilize mast cells. Cell Physiol Biochem. 2025. PMID: 40023811.
Folkerts J et al. Butyrate inhibits human mast cell activation. Allergy. 2020. PMID: 32083336.
Uranga J et al. Nutraceutical regulation of mast cells. Molecules. 2020. PMID: 33023128.
Are you getting the full benefit of a Fullscript account?
If you haven’t already done so, set up your own Fullscript account so you can see my recommended core supplements, Protocols, and other favorites. And if you decide to purchase supplements which I’ve researched and recommend through Fullscript, I receive a small commission — and YOU receive a 10% discount! It’s a win/win.
Canadian residents
USA residents
>>> If you’re having trouble finding my list of Favorite Supplements, I hope this video helps you. <<<
If you’re still unable to see my recommended core supplements in your account, select the ‘Catalog’ tab, then click on ‘Dr. Patricia Mills’ Fullscript Account Favourites’ and then select ‘Foundational Supplements’.



